Typically, the released Cu2+ binds to ferredoxin 1 (FDX1) and reduced to Cu+, while ES chelates and transports extracellular Cu2+ into tumor cells, leading to mitochondrial stress and the disruption of cellular energy 25,26. Here, FDX1 is linked to neoplasm.